317 related articles for article (PubMed ID: 22323726)
1. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.
Harrington AJ; Yacoubian TA; Slone SR; Caldwell KA; Caldwell GA
J Neurosci; 2012 Feb; 32(6):2142-53. PubMed ID: 22323726
[TBL] [Abstract][Full Text] [Related]
2. VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease.
Ruan Q; Harrington AJ; Caldwell KA; Caldwell GA; Standaert DG
Neurobiol Dis; 2010 Feb; 37(2):330-8. PubMed ID: 19850127
[TBL] [Abstract][Full Text] [Related]
3. Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.
Griffin EF; Yan X; Caldwell KA; Caldwell GA
Hum Mol Genet; 2018 Dec; 27(24):4176-4193. PubMed ID: 30508205
[TBL] [Abstract][Full Text] [Related]
4. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Yan J; Yang Z; Zhao N; Li Z; Cao X
BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386
[TBL] [Abstract][Full Text] [Related]
5. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans.
Chang CH; Wei CC; Ho CT; Liao VH
Phytomedicine; 2021 Nov; 92():153733. PubMed ID: 34537465
[TBL] [Abstract][Full Text] [Related]
6. NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease.
Zhang S; Glukhova SA; Caldwell KA; Caldwell GA
Hum Mol Genet; 2017 Oct; 26(19):3823-3836. PubMed ID: 28934392
[TBL] [Abstract][Full Text] [Related]
7. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
Youssef K; Tandon A; Rezai P
Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
[TBL] [Abstract][Full Text] [Related]
8. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.
Yacoubian TA; Slone SR; Harrington AJ; Hamamichi S; Schieltz JM; Caldwell KA; Caldwell GA; Standaert DG
Cell Death Dis; 2010; 1(1):e2. PubMed ID: 21152247
[TBL] [Abstract][Full Text] [Related]
9. RTCB-1 mediates neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway.
Ray A; Zhang S; Rentas C; Caldwell KA; Caldwell GA
J Neurosci; 2014 Nov; 34(48):16076-85. PubMed ID: 25429148
[TBL] [Abstract][Full Text] [Related]
10. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
[TBL] [Abstract][Full Text] [Related]
12. Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.
Chalorak P; Sornkaew N; Manohong P; Niamnont N; Malaiwong N; Limboonreung T; Sobhon P; Aschner M; Meemon K
J Ethnopharmacol; 2021 Oct; 279():114347. PubMed ID: 34147616
[TBL] [Abstract][Full Text] [Related]
13. Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease.
Harrington AJ; Knight AL; Caldwell GA; Caldwell KA
Methods; 2011 Mar; 53(3):220-5. PubMed ID: 21195766
[TBL] [Abstract][Full Text] [Related]
14. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.
Jadiya P; Fatima S; Baghel T; Mir SS; Nazir A
Mol Neurobiol; 2016 Nov; 53(9):6288-6300. PubMed ID: 26567108
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson's disease.
Saewanee N; Praputpittaya T; Malaiwong N; Chalorak P; Meemon K
Neurosci Res; 2021 Jan; 162():13-21. PubMed ID: 31881233
[No Abstract] [Full Text] [Related]
16. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or α-synuclein in Caenorhabditis elegans.
da Cruz Guedes E; Erustes AG; Leão AHFF; Carneiro CA; Abílio VC; Zuardi AW; Hallak JEC; Crippa JA; Bincoletto C; Smaili SS; Reckziegel P; Pereira GJS
Neurochem Res; 2023 Aug; 48(8):2390-2405. PubMed ID: 36964823
[TBL] [Abstract][Full Text] [Related]
18. TDP-1/TDP-43 potentiates human α-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans.
Shen L; Wang C; Chen L; Leung KL; Lo E; Lakso M; Wong G
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165876. PubMed ID: 32531261
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease.
Tsai CW; Tsai RT; Liu SP; Chen CS; Tsai MC; Chien SH; Hung HS; Lin SZ; Shyu WC; Fu RH
Cell Transplant; 2017 Dec; 26(12):1903-1918. PubMed ID: 29390878
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson's disease.
Patel D; Xu C; Nagarajan S; Liu Z; Hemphill WO; Shi R; Uversky VN; Caldwell GA; Caldwell KA; Witt SN
Hum Mol Genet; 2018 May; 27(9):1514-1532. PubMed ID: 29452354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
